SGLT2 inhibition in heart failure with a preserved ejection fraction — A win against a formidable foe

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1522-1524
Number of pages	3
Journal	New England Journal of Medicine
Volume	385
Issue number	16
DOIs	https://doi.org/10.1056/NEJMe2113008
State	Published - Oct 14 2021

ASJC Scopus subject areas

@article{5efaa513e5964010b80b22b6119e774b,

title = "SGLT2 inhibition in heart failure with a preserved ejection fraction — A win against a formidable foe",

author = "Drazner, {Mark H.}",

year = "2021",

month = oct,

day = "14",

doi = "10.1056/NEJMe2113008",

language = "English (US)",

volume = "385",

pages = "1522--1524",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "16",

}

TY - JOUR

T1 - SGLT2 inhibition in heart failure with a preserved ejection fraction — A win against a formidable foe

AU - Drazner, Mark H.

PY - 2021/10/14

Y1 - 2021/10/14

UR - http://www.scopus.com/inward/record.url?scp=85117267880&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85117267880&partnerID=8YFLogxK

U2 - 10.1056/NEJMe2113008

DO - 10.1056/NEJMe2113008

M3 - Editorial

C2 - 34449180

AN - SCOPUS:85117267880

SN - 0028-4793

VL - 385

SP - 1522

EP - 1524

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 16

ER -